{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:44:05Z","timestamp":1773863045195,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":58,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000738","name":"University of Leicester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012151","name":"University Hospitals of Leicester NHS Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000857","name":"Loughborough University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.dsx.2025.103327","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T07:48:14Z","timestamp":1763797694000},"page":"103327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Experience with insulin detemir for type 2 diabetes in older people and people with comorbidities"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9987-9371","authenticated-orcid":false,"given":"Melanie J.","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amra Ciric","family":"Alibegovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5784-308X","authenticated-orcid":false,"given":"Anders Boeck","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renuka","family":"Munikrishnappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2743-4584","authenticated-orcid":false,"given":"Uffe Christian","family":"Braae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.dsx.2025.103327_bib1","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the american diabetes association (ADA) and the european association for the study of diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.dsx.2025.103327_bib2","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.2337\/dc22-S013","article-title":"Older adults: standards of medical care in Diabetes-2022","volume":"45","author":"American Diabetes Association Professional Practice","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2025.103327_bib3","series-title":"Diabetes in America, national institute of diabetes and digestive and kidney diseases (US)","article-title":"Diabetes in older adults","author":"Laiteerapong","year":"2018"},{"issue":"7","key":"10.1016\/j.dsx.2025.103327_bib4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1185\/03007995.2016.1168291","article-title":"Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus","volume":"32","author":"Iglay","year":"2016","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.dsx.2025.103327_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-019-1373-y","article-title":"The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort","volume":"17","author":"Nowakowska","year":"2019","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.dsx.2025.103327_bib6","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/j.1532-5415.2012.04055.x","article-title":"Insulin use in elderly adults: risk of hypoglycemia and strategies for care","volume":"60","author":"Ligthelm","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10.1016\/j.dsx.2025.103327_bib7","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/diabetes.53.6.1614","article-title":"Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes","volume":"53","author":"Heise","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2025.103327_bib8","first-page":"CD006383","article-title":"Insulin detemir versus insulin glargine for type 2 diabetes mellitus","volume":"7","author":"Swinnen","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dsx.2025.103327_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/VHRM.S10397","article-title":"An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog","volume":"6","author":"Raslova","year":"2010","journal-title":"Vasc Health Risk Manag"},{"issue":"17","key":"10.1016\/j.dsx.2025.103327_bib10","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.2165\/11470200-000000000-00000","article-title":"Insulin detemir: a review of its use in the management of diabetes mellitus","volume":"72","author":"Keating","year":"2012","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.dsx.2025.103327_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical practice research datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.dsx.2025.103327_bib12","author":"Davidson"},{"issue":"10","key":"10.1016\/j.dsx.2025.103327_bib13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/dom.12493","article-title":"Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake?","volume":"17","author":"Russell-Jones","year":"2015","journal-title":"Diabetes Obes Metabol"},{"issue":"6","key":"10.1016\/j.dsx.2025.103327_bib14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2146\/ajhp080085","article-title":"Special considerations for treatment of type 2 diabetes mellitus in the elderly","volume":"68","author":"Fravel","year":"2011","journal-title":"Am J Health Syst Pharm"},{"issue":"11","key":"10.1016\/j.dsx.2025.103327_bib15","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/j.1532-5415.2007.01414.x","article-title":"Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials","volume":"55","author":"Garber","year":"2007","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.dsx.2025.103327_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40266-016-0342-9","article-title":"Effects of age on glycemic control in patients with type 2 diabetes treated with insulin detemir: a post-hoc analysis of the PREDICTIVE 303 study","volume":"33","author":"Bhargava","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.dsx.2025.103327_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104215","article-title":"Cardiorenal protection of SGLT2 inhibitors-perspectives from metabolic reprogramming","volume":"83","author":"Gao","year":"2022","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.dsx.2025.103327_bib19","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.3390\/ijms23073651","article-title":"An overview of the cardiorenal protective mechanisms of SGLT2 inhibitors","volume":"23","author":"Salvatore","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.dsx.2025.103327_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1185\/03007995.2015.1135789","article-title":"Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US","volume":"32","author":"Perez-Nieves","year":"2016","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.dsx.2025.103327_bib21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/dom.13200","article-title":"Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiating basal insulin","volume":"20","author":"Zhou","year":"2018","journal-title":"Diabetes Obes Metabol"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402125001444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402125001444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:17:02Z","timestamp":1773836222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402125001444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1871402125001444"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2025.103327","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experience with insulin detemir for type 2 diabetes in older people and people with comorbidities","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2025.103327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC).","name":"copyright","label":"Copyright"}],"article-number":"103327"}}